- Who it's for
- All people with ALS
- Type
- Oral (tablet / liquid / dissolving film)
- How it works
- Reduces glutamate release, which is thought to injure motor neurons at high levels.
Coverage by country
| Country / region | Status | Note |
|---|---|---|
| United States | Approved & reimbursed | Approved 1995; generic, broadly covered. |
| United Kingdom | Approved & reimbursed | NICE-recommended; available on the NHS. |
| Germany | Approved & reimbursed | Approved EU-wide; reimbursed. |
| France | Approved & reimbursed | Approved EU-wide; reimbursed. |
| Japan | Approved & reimbursed | Approved and reimbursed. |
| Canada | Approved & reimbursed | Approved; provincial coverage varies. |
| Australia | Approved & reimbursed | PBS-listed. |